AI enabled
Step change
Aperture is developing ASO therapeutics for neurodegenerative diseases by leveraging insights from the genetic profiles of naturally disease resilient individuals.
Under the radar for now - more info soon.
The latest from
Aperture
Stay up to date on Human 3 - the new epoch of health, wellbeing and performance